Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Bosch

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|April 8, 2021
Is acute lymphoblastic leukemia with mature B-cell phenotype and <i>KMT2A</i> rearrangements a new entity? A systematic review and meta-analysisGloria Hidalgo-Gómez, Carlos Palacio-Garcia, Laura Gallur, et al.
Hemasphere|June 15, 2026
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformationBarbara Eichhorst, Paolo Ghia, Francesc Bosch, et al.
British Journal of Haematology|December 11, 2002
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemiaFrancesc Bosch, Anna Ferrer, Armando López-Guillermo, et al.
Frontiers in Immunology|May 8, 2023
G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapyMarcelo Lima Ribeiro, Núria Profitós-Pelejà, Juliana Carvalho Santos, et al.
Transplantation and Cellular Therapy|September 28, 2020
Analysis of Cell Subsets in Donor Lymphocyte Infusions from HLA Identical Sibling Donors after Allogeneic Hematopoietic Cell TransplantGuillermo Ortí, Carles Palacio-Garcia, Irene García-Cadenas, et al.
Annals of Hematology|July 8, 2021
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapyGloria Iacoboni, Marc Simó, Guillermo Villacampa, et al.
Haematologica|April 28, 2010
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behaviorEva Giné, Antoni Martinez, Neus Villamor, et al.
Annals of Hematology|January 22, 2025
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemiaGloria Hidalgo-Gómez, Bárbara Tazón-Vega, Carlos Palacio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapySilvia Marcé, Olga Balagué, Luis Colomo, et al.
Leukemia & Lymphoma|April 26, 2021
Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European centerCecilia Carpio, Gloria Iacoboni, Guillermo Villacampa, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|April 8, 2021
Is acute lymphoblastic leukemia with mature B-cell phenotype and <i>KMT2A</i> rearrangements a new entity? A systematic review and meta-analysisGloria Hidalgo-Gómez, Carlos Palacio-Garcia, Laura Gallur, et al.
Hemasphere|June 15, 2026
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformationBarbara Eichhorst, Paolo Ghia, Francesc Bosch, et al.
British Journal of Haematology|December 11, 2002
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemiaFrancesc Bosch, Anna Ferrer, Armando López-Guillermo, et al.
Frontiers in Immunology|May 8, 2023
G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapyMarcelo Lima Ribeiro, Núria Profitós-Pelejà, Juliana Carvalho Santos, et al.
Transplantation and Cellular Therapy|September 28, 2020
Analysis of Cell Subsets in Donor Lymphocyte Infusions from HLA Identical Sibling Donors after Allogeneic Hematopoietic Cell TransplantGuillermo Ortí, Carles Palacio-Garcia, Irene García-Cadenas, et al.
Annals of Hematology|July 8, 2021
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapyGloria Iacoboni, Marc Simó, Guillermo Villacampa, et al.
Haematologica|April 28, 2010
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behaviorEva Giné, Antoni Martinez, Neus Villamor, et al.
Annals of Hematology|January 22, 2025
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemiaGloria Hidalgo-Gómez, Bárbara Tazón-Vega, Carlos Palacio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapySilvia Marcé, Olga Balagué, Luis Colomo, et al.
Leukemia & Lymphoma|April 26, 2021
Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European centerCecilia Carpio, Gloria Iacoboni, Guillermo Villacampa, et al.
Pageof 17